Navigation Links
BioLineRx Announces New Positive Results in Phase 2a trial for Orally Available Inflammatory Bowel Disease Treatment
Date:11/26/2013

-9). It also acts as a specific suppressor of acetylcholinesterase, a key enzyme involved in neurological pathways. This dual effect enables a unique combination of both neurological and anti-inflammatory properties. In addition, BL-7040 has an indirect effect on the production of pro-inflammatory cytokines as well as anti-inflammatory properties via modulation of macrophages. BL-7040 was invented by Prof. Hermona Soreq from the Hebrew University of Jerusalem, and is being developed by BioLineRx under a worldwide exclusive license from Yissum Research and Development Company, the technology transfer company of the Hebrew University.

About Inflammatory Bowel Disease (IBD)              
Inflammatory bowel disease is a chronic inflammatory gastrointestinal disease characterized by chronic abdominal pain, discomfort, bloating and alteration of bowel habits. Over two million people are afflicted with IBD in the seven major markets. Sales of existing drugs in the seven major markets were estimated at over $7.5 billion in 2012, of which $5.6 billion were US-based sales. By 2020, sales in the seven major markets are expected to be over $8 billion, of which $6.5 billion are expected to be in the US. Despite these numbers, there is still a significant portion of IBD patients who are underserved by current pharmacological treatments.

About BioLineRx        
BioLineRx is a publicly-traded biopharmaceutical development company dedicated to building a portfolio of products for unmet medical needs, as well as those with advantages over currently available therapies. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages,
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
2. BioLineRx Reports Third Quarter 2013 Financial Results
3. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
4. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
5. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
7. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
8. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
9. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
10. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
11. BioLineRx to Present at 15th International Celiac Disease Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... LOS ANGELES , April 28, 2015  Illnesses know ... case with our places of business. If you,ve ever woken ... you are as sick as the proverbial dog, or if ... can,t figure out how to fit it into your schedule, ... , M.D. of House Call Doctor Los Angeles offers an ...
(Date:4/28/2015)... 28, 2015   Generational Equity , a leading ... pleased to announce the acquisition of its client, Reuss ... , by Lifecare Pharmacy headquartered in San ... 1, 2015. Reuss Pharmacies Inc. (Reuss) ... retailer of durable medical equipment. Reuss offers a variety ...
(Date:4/28/2015)... April 28, 2015 Konica Minolta Medical ... sales growth for fiscal year ended March 31, ... family of Primary Imaging Solutions.  The success of ... growth to double digit sales figures exceeding expectations.  ... the AeroDR XE, a wireless flat panel detector, ...
Breaking Medicine Technology:Your Health and Your Schedule Should not be at War 2Generational Equity Announces the Acquisition of Reuss Pharmacies Inc. by Lifecare Pharmacy 2Konica Minolta Sets Record Digital Radiography Sales 2
... 3, 2011 Clinicians may soon have a new tool ... – one of the most common sexually transmitted infections in ... and Company) (NYSE: BDX ), announced today that ... clearance for the first fully automated molecular tests to diagnose ...
... 2011 See video from Endo Pharmaceuticals at: ... The FDA has approved Fortesta™ (testosterone) ... low testosterone or "Low T," a condition that ... States. Available content includes an audio news release, ...
Cached Medicine Technology:New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
(Date:4/28/2015)... 28, 2015 Aultman Hospital in ... (WCA) to transition its outpatient wound center electronic ... commitment to the specialty of wound care by ... country currently working with Wound Care Advantage ... wound care treatments and hyperbaric oxygen therapy to ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Consolidated ... are moving forward nationwide, as courts overseeing proceedings ... next month. According to court documents issued in ... the next status conference in the federal Xarelto ... 9:00 a.m. C.S.T. (In Re: Xarelto Products ...
(Date:4/28/2015)... Seton Hall University Provost Larry A. Robinson has ... Dean of Seton Hall School of Law. She will begin ... Boozang, currently Associate Dean for Academic Advancement and Professor of ... launch and currently directs the school’s prestigious Center for ... 10 law health program by U.S. News & World Report ...
(Date:4/28/2015)... 2015 April 8th, 2015, saw ... “RockNRolla Movie Awards” EcoLuxe Lounge, with Choices Recovery ... Entertainment, Los Angeles’ leading producer of sustainable product ... force behind this event, which featured some of ... conscious products and services. The EcoLuxe Lounge is ...
(Date:4/28/2015)... April 28, 2015 Children’s Medical ... the cause of medical foods and formulas through ... as the organization’s new executive director. , Thousands ... health consequences because of conditions and diseases that ... diet. To live and thrive, they are ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2
... March 23 Master,s and doctoral degree ... Carolina public and private colleges and universities may ... for the 2010-11 academic year at the college information ... for the coming year, according to the North Carolina ...
... teleconference is just as effective as face-to-face sessions, according ... professor at the Universit de Montral. "Previous ... just as efficient as face to face contact," says ... Studies Centre at the Louis-H. Lafontaine Hospital,s Fernand-Seguin Research ...
... protein changes in the blood linked to alcohol use may ... currently available, according to Penn State College of Medicine researchers. ... substance abuse -- things like cocaine or heroin or PCP ... those over 21," said Willard M. Freeman, Ph.D., department of ...
... ... replacement, may be an appropriate first step for many people with knee joint arthritis ... the long-term feasibility of artificial knee replacement. , ... San Francisco, CA (PRWEB) March 22, 2010 -- Biologic ...
... Toys“R”Us, ... in April Activities , ... New York, NY (PRWEB) March 23, 2010 -- Autism Speaks ... awareness and fundraising initiatives involving a range of corporate and philanthropic partners that will ...
... that replacing saturated fats has heart benefits , ... with polyunsaturated fats may reduce your risk of heart ... Health researchers reviewed eight studies with a total of ... fats in their diet with polyunsaturated fats had a ...
Cached Medicine News:Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 2Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 3Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 4Health News:Therapy via teleconference? 2Health News:Proteins may point to alcohol use test 2Health News:Proteins may point to alcohol use test 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 2Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 4Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 2Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 3Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 4Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 6Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 7Health News:Polyunsaturated Fats Really May Lower Heart Risk 2
The Shandon Manual Staining Station is ideal for special processes, frozen sections, special stains and low volume procedures....
The Shandon Finesse 315 low-cost precision microtome is ergonomically designed to consistently produce high quality routine paraffin sections without user strain or fatigue....
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
Medicine Products: